• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Sharon Kingman

Sharon Kingman

Articles

ARTICLES

Hope Rising for Oral Drug in Neurodegenerative Diseases

Oct. 16, 2013
By Sharon Kingman
LONDON – Signs of neurodegeneration in a mouse model of Alzheimer’s disease can be halted with a compound that can be taken by mouth, a new study has shown.
Read More

New Automated System Puts Active Genes in the Spotlight

Oct. 11, 2013
By Sharon Kingman
LONDON – It is now possible to measure the activity of a multitude of genes in thousands of cells at once. The new method means that researchers will be able to rapidly detect differences in gene activity among the many cells of a tumor, for example, or among those of a tissue, whether healthy or diseased.
Read More

New Automated System Puts Active Genes in the Spotlight

Oct. 9, 2013
By Sharon Kingman
LONDON – It is now possible to measure the activity of a multitude of genes in thousands of cells at once. The new method means that researchers will be able to rapidly detect differences in gene activity among the many cells of a tumor, for example, or among those of a tissue, whether healthy or diseased.
Read More

Remodeled Brain Circuits Hold Addiction Key, Study Suggests

Oct. 4, 2013
By Sharon Kingman
LONDON – A new understanding of how the neural circuits in the brain alter following exposure to addictive drugs such as cocaine could allow researchers to identify targets for drugs to treat addiction.
Read More

Remodeled Brain Circuits Hold Addiction Key, Study Suggests

Oct. 2, 2013
By Sharon Kingman
LONDON – A new understanding of how the neural circuits in the brain alter following exposure to addictive drugs such as cocaine could allow researchers to identify targets for drugs to treat addiction.
Read More

Flip Side of Mental Retardation Protein Is Cancer Metastasis

Sep. 25, 2013
By Sharon Kingman
LONDON – A protein that has a role in causing the most frequent form of inherited mental retardation has turned out to be a master regulator of a large group of molecules involved in cancer progression and metastasis.
Read More

Flip Side of Mental Retardation Protein Is Cancer Metastasis

Sep. 25, 2013
By Sharon Kingman
LONDON – A protein that has a role in causing the most frequent form of inherited mental retardation has turned out to be a master regulator of a large group of molecules involved in cancer progression and metastasis.
Read More

Screening Study Delivers a New Target For Cystic Fibrosis

Sep. 18, 2013
By Sharon Kingman
LONDON – The prospects for new drugs to treat cystic fibrosis have improved, following a project to screen thousands of genes to determine which of their protein products affects the function of a molecular sodium channel found on cell membranes.
Read More

Screening Study Delivers a New Target for Cystic Fibrosis

Sep. 18, 2013
By Sharon Kingman
LONDON – The prospects for new drugs to treat cystic fibrosis have improved, following a project to screen thousands of genes to determine which of their protein products affects the function of a molecular sodium channel found on cell membranes.
Read More

mRNA Therapy Improves Heart Attack Survival in Mice

Sep. 11, 2013
By Sharon Kingman
LONDON – Delivering synthetic messenger RNA that encodes the right growth factor directly to the heart muscle shortly after a heart attack can induce heart stem cells to divide and mature into new blood vessels, a new study has shown. Mice treated in that way showed a long-term increase in survival.
Read More
View All Articles by Sharon Kingman

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 27, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 27, 2025.
  • Deal handshake with coin, chart background

    After axing 95% workforce, Vor bets $4B+ on Remegen’s telitacicept

    BioWorld
    Just a month after laying off 147 employees and announcing plans to mull “strategic alternatives,” Vor Biopharma Inc. reported raising $175 million in private...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 24, 2025
  • !insulet dexcom CGM

    Pump manufacturers: Patches are the fix for low AID uptake

    BioWorld MedTech
    The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with clear health benefits and payer...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe